SCULLY WILLIAM P purchased $1.0M of PRTA
SCULLY WILLIAM P purchased 125,000 shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at $8.17 ($1.02M total) on 2026-06-11.
How this was made
The 30-second read
Why it matters
This adds a fresh datapoint on insider positioning, which may slightly influence sentiment but does not change the company’s disclosed fundamentals by itself.
Market read
A newly filed insider buy (~$1.02M) may provide a small sentiment tailwind, but it is unlikely to drive a sustained repricing without additional company catalysts.
What to watch
The article provides no follow-on context (e.g., rationale, lockups, other insider trades, or concurrent company catalysts), so traders should avoid extrapolating to near-term fundamentals.
Background
The article is an SEC Form 4 insider transaction disclosure for Prothena (PRTA), reporting a 10% owner open-market purchase.
Ticker impact
PRTA disclosed a 10% owner open-market purchase: 125,000 shares bought on 2026-06-11 for ~$1.02M via SEC Form 4.
Likely limited near-term impact; any effect should be small and fade unless followed by additional company-specific news.
The filing is primary-source and time-stamped, but the transaction is an insider ownership change without new operational/regulatory/clinical information.
Market effects
Minimal; this is company-specific insider activity with no stated sector-wide development.
None indicated.
None indicated.
Counterpoint
Insider purchases under 10b5-1 are not indicated here, but insider buying can still reflect diversification, liquidity planning, or pre-existing intent rather than a new fundamental view.
Key entities
- issuerPROTHENA CORP PUBLIC LTD CO
Subject of the SEC Form 4 insider transaction disclosure (PRTA).
- insiderSCULLY WILLIAM P
10% owner reporting an open-market purchase of PRTA shares.
